🍽️ lynestrenol,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Contraception:

    • Lynestrenol is primarily used as a component of hormonal contraceptive pills to prevent pregnancy. It works by inhibiting ovulation, thickening cervical mucus to prevent sperm penetration, and altering the endometrium to make it less receptive to implantation of a fertilized egg.
  2. Menstrual Disorders:

    • Lynestrenol may be prescribed to regulate menstrual cycles and treat various menstrual disorders such as irregular periods, heavy menstrual bleeding (menorrhagia), and painful periods (dysmenorrhea). It can help in establishing a regular menstrual pattern and reducing menstrual-related symptoms.
  3. Endometriosis:

    • Lynestrenol may also be used in the treatment of endometriosis, a condition characterized by the growth of endometrial tissue outside the uterus. By suppressing ovulation and reducing estrogen levels, lynestrenol helps alleviate symptoms such as pelvic pain, dysmenorrhea, and dyspareunia associated with endometriosis.
  4. Hormone Replacement Therapy (HRT):

    • In some cases, lynestrenol may be included in hormone replacement therapy regimens, especially for women who have undergone surgical menopause (e.g., removal of ovaries). It can help relieve menopausal symptoms such as hot flashes, vaginal dryness, and mood swings.
  5. Breastfeeding Women:

    • Lynestrenol is considered safe for use by breastfeeding women since it does not significantly interfere with lactation or affect the quality of breast milk. However, it is advisable to consult a healthcare provider before starting any medication while breastfeeding.
  6. Side Effects:

    • Common side effects of lynestrenol may include nausea, breast tenderness, headache, mood changes, weight changes, and changes in libido. These side effects are usually mild and tend to improve with continued use.
    • Some women may experience irregular bleeding or spotting, especially during the first few months of using lynestrenol. If these symptoms persist or worsen, medical advice should be sought.
  7. Precautions:

    • Lynestrenol should not be used by women with a history of thromboembolic disorders, liver disease, breast cancer, or undiagnosed vaginal bleeding.
    • It is important to inform healthcare providers about any existing medical conditions, medications, or allergies before starting lynestrenol therapy to minimize the risk of adverse effects and drug interactions.
  8. Effectiveness:

    • Lynestrenol is highly effective as a contraceptive when taken consistently and correctly. However, its effectiveness may be reduced if doses are missed or if it is not taken at the same time every day.
;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of lynestrenol,(prescription) On Probiotics

Rank Probiotic Impact
species Bifidobacterium adolescentis Reduces
species Bifidobacterium longum Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by lynestrenol,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Ruminococcus genus Decreases 👪 Source Study
Clostridioides genus Decreases 👪 Source Study
Segatella genus Decreases 👪 Source Study
Clostridium genus Decreases 👪 Source Study Pathogen
Roseburia genus Decreases 👪 Source Study
Coprococcus genus Decreases 👪 Source Study
Blautia genus Decreases 👪 Source Study
Mediterraneibacter genus Decreases 👪 Source Study
Odoribacter genus Decreases 👪 Source Study
Agathobacter genus Decreases 👪 Source Study
Bacteroides genus Decreases 👪 Source Study
Bifidobacterium genus Decreases 👪 Source Study
Veillonella genus Decreases 👪 Source Study
Parabacteroides genus Decreases 👪 Source Study BMI, fat percent,blood pressure
Phocaeicola genus Decreases 👪 Source Study
Dorea genus Decreases 👪 Source Study
Streptococcus genus Decreases 👪 Source Study
Collinsella genus Decreases 👪 Source Study proinflammatory
Enterocloster genus Decreases 👪 Source Study
Lacrimispora genus Decreases 👪 Source Study
Bilophila genus Decreases 👪 Source Study High Level Cause Brain Fog(Cognitive impairment)
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
Eggerthellales order Decreases ⚗️ Source Study
Ruminococcus bromii species Decreases 📓 Source Study
[Ruminococcus] torques species Decreases 📓 Source Study
Clostridioides difficile species Decreases 📓 Source Study Colitis
Segatella copri species Decreases 📓 Source Study Over 70%ile Indicator of mycotoxin present
Clostridium perfringens species Decreases 📓 Source Study Food poisoning, gas gangrene
Roseburia intestinalis species Decreases 📓 Source Study
Coprococcus comes species Decreases 📓 Source Study
Bifidobacterium longum species Decreases 📓 Source Study
Parabacteroides merdae species Decreases 📓 Source Study Infectious bacteria
Blautia obeum species Decreases 📓 Source Study
Odoribacter splanchnicus species Decreases 📓 Source Study
[Ruminococcus] gnavus species Decreases 📓 Source Study
Bacteroides ovatus species Decreases 📓 Source Study
Streptococcus parasanguinis species Decreases 📓 Source Study
Bacteroides fragilis species Decreases 📓 Source Study H02076 Bacteroides infection
Agathobacter rectalis species Decreases 📓 Source Study
Bacteroides caccae species Decreases 📓 Source Study
Veillonella parvula species Decreases 📓 Source Study
Phocaeicola vulgatus species Decreases 📓 Source Study
Dorea formicigenerans species Decreases 📓 Source Study
Bacteroides uniformis species Decreases 📓 Source Study Infectious bacteria
Collinsella aerofaciens species Decreases 📓 Source Study
Bifidobacterium adolescentis species Decreases 📓 Source Study
Enterocloster bolteae species Decreases 📓 Source Study
Parabacteroides distasonis species Decreases 📓 Source Study
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Streptococcus salivarius species Decreases 📓 Source Study Infectious bacteria
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Lacrimispora saccharolytica species Decreases 📓 Source Study
Bilophila wadsworthia species Decreases 📓 Source Study
Coriobacterineae suborder Decreases ⚗️ Source Study
Bifidobacterium longum subsp. infantis subspecies Decreases 👶 Source Study
Bifidobacterium longum subsp. longum subspecies Decreases 👶 Source Study
Bifidobacterium longum subsp. suillum subspecies Decreases 👶 Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of lynestrenol,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0 0
Acne 0.3 -0.3
ADHD 5.1 0.5 9.2
Age-Related Macular Degeneration and Glaucoma 0.7 0.3 1.33
Allergic Rhinitis (Hay Fever) 2 1.7 0.18
Allergies 4.5 2.8 0.61
Allergy to milk products 1.3 0.6 1.17
Alopecia (Hair Loss) 1.2 1.2
Alzheimer's disease 3 6.4 -1.13
Amyotrophic lateral sclerosis (ALS) Motor Neuron 2.3 0.5 3.6
Ankylosing spondylitis 3 1.7 0.76
Anorexia Nervosa 0.3 2.7 -8
Antiphospholipid syndrome (APS) 1.2 0 0
Asthma 0.8 0.8 0
Atherosclerosis 1 2.9 -1.9
Atrial fibrillation 3.6 2 0.8
Autism 10.2 8.7 0.17
Barrett esophagus cancer 0.3 0.2 0.5
Bipolar Disorder 1.2 1.8 -0.5
Brain Trauma 0.5 0.8 -0.6
Cancer (General) 0.5 3.3 -5.6
Carcinoma 3.1 2.8 0.11
Celiac Disease 1.9 4 -1.11
Cerebral Palsy 1.4 1.8 -0.29
Chronic Fatigue Syndrome 6.3 7.9 -0.25
Chronic Kidney Disease 2.5 1.9 0.32
Chronic Lyme 0.8 -0.8
Chronic Obstructive Pulmonary Disease (COPD) 1.5 1 0.5
Chronic Urticaria (Hives) 1 1.7 -0.7
Coagulation / Micro clot triggering bacteria 0.5 1.7 -2.4
Colorectal Cancer 3.3 0.9 2.67
Constipation 0.9 1 -0.11
Coronary artery disease 1.9 1.3 0.46
COVID-19 8.9 12.8 -0.44
Crohn's Disease 6.8 5.3 0.28
cystic fibrosis 1.2 -1.2
deep vein thrombosis 1.2 -1.2
Depression 8 8.5 -0.06
Dermatomyositis 0.2 0.3 -0.5
Eczema 1.2 1.9 -0.58
Endometriosis 2.4 1.3 0.85
Eosinophilic Esophagitis 0.3 -0.3
Epilepsy 2.3 2.4 -0.04
Fibromyalgia 3 3.6 -0.2
Functional constipation / chronic idiopathic constipation 6.1 5.5 0.11
gallstone disease (gsd) 2.3 0.8 1.87
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 1.7 1.2 0.42
Generalized anxiety disorder 1.4 2.6 -0.86
giant cell arteritis 0.5 -0.5
Glioblastoma 0.2 -0.2
Gout 0.5 -0.5
Graves' disease 1.2 1.4 -0.17
Halitosis 0.7 0.2 2.5
Hashimoto's thyroiditis 2.9 0.7 3.14
Hidradenitis Suppurativa 0.3 0.3 0
Histamine Issues 2.8 1.3 1.15
hypercholesterolemia (High Cholesterol) 1 1
hyperglycemia 1.5 -1.5
Hyperlipidemia (High Blood Fats) 0.5 0.2 1.5
hypersomnia 0.5 -0.5
hypertension (High Blood Pressure 1.9 4.6 -1.42
Hypothyroidism 1.3 -1.3
Hypoxia 0.6 0.6
IgA nephropathy (IgAN) 4 -4
Inflammatory Bowel Disease 2.8 9.5 -2.39
Insomnia 1 0.8 0.25
Intelligence 1.4 1 0.4
Intracranial aneurysms 1.6 0.2 7
Irritable Bowel Syndrome 3.1 3.7 -0.19
Liver Cirrhosis 4.7 3.5 0.34
Long COVID 6.5 7.9 -0.22
Low bone mineral density 1 -1
Lung Cancer 0.7 1.2 -0.71
Mast Cell Issues / mastitis 0.2 1.3 -5.5
ME/CFS with IBS 1.1 3.1 -1.82
ME/CFS without IBS 1.7 1.7 0
Menopause 2.2 2.2
Metabolic Syndrome 7.3 7.9 -0.08
Mood Disorders 10.9 8.5 0.28
multiple chemical sensitivity [MCS] 0.7 0.5 0.4
Multiple Sclerosis 4 6.1 -0.52
Multiple system atrophy (MSA) 0.8 1.3 -0.63
neuropathic pain 0.7 -0.7
Neuropathy (all types) 0.7 0.7
neuropsychiatric disorders (PANDAS, PANS) 0.5 0.5
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 2.6 5.6 -1.15
NonCeliac Gluten Sensitivity 0.3 -0.3
Obesity 8.5 3.5 1.43
obsessive-compulsive disorder 6.8 5.6 0.21
Osteoarthritis 1.9 0.5 2.8
Osteoporosis 1.7 0.8 1.13
pancreatic cancer 0.7 0.7
Parkinson's Disease 1.6 4.6 -1.87
Polycystic ovary syndrome 2.7 2.8 -0.04
Postural orthostatic tachycardia syndrome 0.5 0.8 -0.6
Premenstrual dysphoric disorder 1 0.3 2.33
primary biliary cholangitis 0.2 0.6 -2
Psoriasis 4 2.9 0.38
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 5.9 4.1 0.44
Rosacea 1.8 1 0.8
Schizophrenia 6.6 2.8 1.36
scoliosis 0.5 0.5 0
Sjögren syndrome 3.4 2.9 0.17
Sleep Apnea 1.8 1.8 0
Small Intestinal Bacterial Overgrowth (SIBO) 0.2 1 -4
Stress / posttraumatic stress disorder 2.2 1.8 0.22
Systemic Lupus Erythematosus 4.3 2.3 0.87
Tic Disorder 1.6 1.8 -0.13
Tourette syndrome 0.3 -0.3
Type 1 Diabetes 4.4 2.2 1
Type 2 Diabetes 7.4 6 0.23
Ulcerative colitis 2.1 5.9 -1.81
Unhealthy Ageing 6 2.5 1.4

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant or equivalent EU laws. [34.239.170 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [34.239.170 ]